Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 23Triple Negative Breast Neoplasms 2Unilateral Breast Neoplasms 1Social Isolation 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasm Micrometastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1COVID-19 1Breast Cancer Female 1BRCA1/2 Mutation 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Mastectomy, Segmental × Clear all
NCT07211451 2025-10-08

Axillary Nodal Burden in HER2+ and TNBC

Gangnam Severance Hospital

Completed
1,571 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01805076 2025-09-05

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
317 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡